Drug intelligence / Profile preview

phloroglucinol

Development stage
Phase 4
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Rectal
01

Overview

Phloroglucinol is a non-atropinic, musculotropic antispasmodic agent used primarily for the symptomatic treatment of pain related to functional disorders of the gastrointestinal tract, biliary tract, and urinary tract, as well as for acute spasmodic pain in gynecology. Unlike anticholinergic antispasmodics, phloroglucinol acts directly on smooth muscle fibers, inhibiting spasms without inducing the typical side effects associated with atropine-like drugs, such as dry mouth, tachycardia, or blurred vision. Its mechanism of action involves the inhibition of voltage-gated calcium channels and potentially the modulation of other intracellular signaling pathways in smooth muscle cells. It is frequently utilized in the management of renal colic, biliary colic, and dysmenorrhea, and is also used in obstetrics to facilitate cervical dilation during labor.

Brand names
SpasfonSpasmylFloroglucinolSpasfon-Lyoc
Other names
1,3,5-trihydroxybenzenephloroglucinbenzene-1,3,5-triol间苯三酚
02

Targets

COMT (Catechol-O-methyltransferase)CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on phloroglucinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phloroglucinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call